Ventrinova Company
VentriNova is revolutionizing cardiac regenerative medicine by reversing cardiac damage pharmacologically.
Industry:
Gene Therapy
Technology:
Cardiovascular Disorders
Headquarters:
New York, New York, United States
Founded Date:
2006
Funding Status:
Seed